As of 2026-09-26, the Relative Valuation of Cullinan Oncology Inc (CGEM) is (72.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.81 USD, the upside of Cullinan Oncology Inc based on Relative Valuation is -592.8%.
The range of the Relative Valuation is (66.63) - (78.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.6x - 30.3x | 28.0x |
| Forward P/E multiples | 25.7x - 31.0x | 28.4x |
| Fair Price | (66.63) - (78.56) | (72.99) |
| Upside | -549.9% - -630.4% | -592.8% |
| Date | P/E |
| 2026-09-22 | -8.36 |
| 2026-09-21 | -8.23 |
| 2026-09-18 | -8.13 |
| 2026-09-17 | -8.24 |
| 2026-09-16 | -7.96 |
| 2026-09-15 | -7.92 |
| 2026-09-14 | -7.87 |
| 2026-09-11 | -7.94 |
| 2026-09-10 | -8.10 |
| 2026-09-09 | -8.22 |
| 2026-09-08 | -8.37 |
| 2026-09-04 | -8.52 |
| 2026-09-03 | -8.55 |
| 2026-09-02 | -8.61 |
| 2026-09-01 | -8.40 |
| 2026-08-31 | -8.51 |
| 2026-08-28 | -8.37 |
| 2026-08-27 | -8.72 |
| 2026-08-26 | -8.81 |
| 2026-08-25 | -8.85 |
| 2026-08-24 | -8.42 |
| 2026-08-21 | -8.36 |
| 2026-08-20 | -8.25 |
| 2026-08-19 | -8.69 |
| 2026-08-18 | -8.04 |
| 2026-08-17 | -7.94 |
| 2026-08-14 | -7.85 |
| 2026-08-13 | -7.58 |
| 2026-08-12 | -7.56 |
| 2026-08-11 | -7.57 |
| 2026-08-10 | -7.05 |
| 2026-08-07 | -6.84 |
| 2026-08-06 | -6.92 |
| 2026-08-05 | -6.79 |
| 2026-08-04 | -6.77 |
| 2026-08-03 | -6.27 |
| 2026-07-31 | -6.36 |
| 2026-07-30 | -6.76 |
| 2026-07-29 | -6.64 |
| 2026-07-28 | -6.74 |
| 2026-07-27 | -6.72 |
| 2026-07-24 | -6.60 |
| 2026-07-23 | -6.66 |
| 2026-07-22 | -6.81 |
| 2026-07-21 | -6.97 |
| 2026-07-20 | -6.75 |
| 2026-07-17 | -6.82 |
| 2026-07-16 | -6.33 |
| 2026-07-15 | -6.88 |
| 2026-07-14 | -6.85 |